TITLE

Substituting placebo for established, effective therapy: Why not?

AUTHOR(S)
Shapiro, Stan; Fergusson, Dean; Cranley Glass, Kathleen
PUB. DATE
November 2010
SOURCE
CMAJ: Canadian Medical Association Journal;11/9/2010, Vol. 182 Issue 16, p1749
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
The article offers the authors' insights on substituting placebo for established, effective therapy. They tackle the practical implications of assay sensitivity and explore the reasons why some still endorse and strongly advocate for placebo controls despite its ethical concerns. They believe that placebo controls have an important role in randomized controlled trials but stress the significance of examining the decisions about their use.
ACCESSION #
55161345

 

Related Articles

  • Non-deceptive options do exist.  // Medical Ethics Advisor;8/1/2012, p92 

    The article focuses on the ethical concern regarding utilization of placebos in medicine.

  • Placebos: What place do they have in medicine?  // Medical Ethics Advisor;8/1/2012, p91 

    The article focuses on the ethical issues regarding the policy of the American Medical Association (AMA) which prohibits doctors from giving substances that they believe are placebos to their patients. It notes that undisclosed utilization of placebos could violate the autonomy of patient. It...

  • Ethical gray area: What is a placebo?  // Medical Ethics Advisor;8/1/2012, p92 

    The article focuses on the ethical concern on the use of placebo in medicine. It mentions an incident when a doctor provides a treatment which he or she understands to be effective for the condition being treated, however, the doctor does not know whether it works through a placebo effect. It...

  • Attitudes toward Placebo-Controlled Clinical Trials of Patients with Schizophrenia in Japan. Sugawara, Norio; Ishioka, Masamichi; Tsuchimine, Shoko; Tsuruga, Koji; Sato, Yasushi; Furukori, Hanako; Kudo, Shuhei; Tomita, Tetsu; Nakagami, Taku; Yasui-Furukori, Norio // PLoS ONE;11/24/2015, Vol. 10 Issue 11, p1 

    Background: Although the use of placebo in clinical trials of schizophrenia patients is controversial because of medical and ethical concerns, placebo-controlled clinical trials are commonly used in the licensing of new drugs. Aims: The objective of this study was to assess the attitudes...

  • Philosophical clinical ethics. Dawson, Angus; Wilkinson, Stephen // Clinical Ethics;2009, Vol. 4 Issue 1, p36 

    The article discusses various reports published within the issue, including one by Eve Garrard and Anthony Wrigley on the concept of "hope" in relative to its role in palliative treatment, one by Nafsika Athanassoulis on the concept of deception in medical research, and another by Jonathan...

  • Placebo -- More hatred than love. Hong-Liang Zhang // Journal of Neurosciences in Rural Practice;Jan-Jun2011, Vol. 2 Issue 1, p105 

    A placebo is a sham medical intervention that can produce a placebo eff ect. Laboratory evidence supports the existence of several mechanisms of placebo effects in both healthy population and patients with a variety of medical conditions. The ethics of placebos have long been debated. However,...

  • So-Called "Clinical Equipoise" and the Argument from Design. Gifford, Fred // Journal of Medicine & Philosophy;Mar/Apr2007, Vol. 32 Issue 2, p135 

    In this article, I review and expand upon arguments showing that Freedman's so-called "clinical equipoise" criterion cannot serve as an appropriate guide and justification for the moral legitimacy of carrying out randomized clinical trials. At the same time, I try to explain why this approach...

  • A renewed, ethical defense of placebo-controlled trials of new treatments for major depression and anxiety disorders. Dunlop, B. W.; Banja, J. // Journal of Medical Ethics;Jun2009, Vol. 35 Issue 6, p384 

    The use of placebo as a control condition in clinical trials of major depressive disorder and anxiety disorders continues to be an area of ethical concern. Typically, opponents of placebo controls argue that they violate the beneficent-based, "best proven diagnostic and therapeutic method" that...

  • Clarifying best interests. Sokol, Daniel K. // BMJ: British Medical Journal (International Edition);8/2/2008, Vol. 337 Issue 7664, p264 

    The author reflects on issues physicians should consider when determining what is best for their patients in terms of care and treatment. He suggests that it is important for physicians to put themselves in their patients' shoes and imagine what it is like to be a patient. He argues that...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics